Creation of highly efficient recombinant viral vectors for development of prime-boost vaccines: Matrix protein gene variants of two antigenically distinct serotypes of vesicular stomatitis virus are ideal vaccine vectors
vaccination, the priming recombinant viral vector should be antigenically distinct from the boost vaccine vector. A priming vaccine vector will most likely induce neutralizing antibodies which will neutralize the…

